Companies /Real Estate

Ventas Inc

NYSE: VTR Reit - Healthcare Facilities
$90.27
▼ $1.84 (−2.00%) today
Markets closed · 8:39am ET

Q2 2025 Earnings

Reported Jul 30, 2025, 4:30pm ET · SEC source
$0.15
Beat +0.00%
EPS · est. $0.00
$1.4B
Beat +3.69%
Revenue · est. $1.4B
−0.2%
Trailing market
VTR vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
0+2%Jul 30Jul 31report 4:30pm ETearnings−1.0%+1.1%
0+2%Jul 30Jul 31earnings−1.0%+1.1%
VTR +1.1%S&P 500 −1.0%
0+2%Jul 30Jul 31report 4:30pm ETearnings−1.4%+1.1%
0+2%Jul 30Jul 31earnings−1.4%+1.1%
VTR +1.1%NASDAQ −1.4%
−3%0+3%+6%Jul 29Aug 7report 4:30pm ETearnings−0.7%+5.7%
−3%0+3%+6%Jul 29Aug 7earnings−0.7%+5.7%
VTR +5.7%S&P 500 −0.7%
−3%0+3%+6%Jul 29Aug 7report 4:30pm ETearnings−0.4%+5.7%
−3%0+3%+6%Jul 29Aug 7earnings−0.4%+5.7%
VTR +5.7%NASDAQ −0.4%
+1.05%
Day of report
+0.48%
Next session
+2.28%
One week
+1.10%
30 days

S&P 500 over the same 30 days: +1.30%.

Did VTR Beat Earnings? Q2 2025 Results

Ventas delivered a strong second quarter in 2025, with revenue of $1.42 billion coming in 3.69% above consensus estimates and rising 18.3% year-over-year, as the healthcare REIT's Senior Housing Operating Portfolio continued to fire on all cylinders. GAAP EPS of $0.15 cleared the $0 consensus, while Normalized FFO per share of $0.87 grew 9% year-over-year, reflecting the depth of the operating momentum. The primary engine was SHOP, where Same-Store Cash NOI surged 13.3% year-over-year on the back of 8% same-store revenue growth, average occupancy gains of 240 basis points, and Revenue per Occupied Room growth of 5%, all supported by what CEO Debra Cafaro described as an "unprecedented" and multiyear demographic opportunity in senior housing. The broad-based demand environment in the sector, visible across multiple operators this earnings season, adds further conviction to Ventas's growth thesis. Looking ahead, management raised its full-year 2025 Normalized FFO per share guidance to $3.41-$3.46 and lifted its senior housing investment volume target to $2.00 billion, underscoring confidence in the acquisition pipeline.

Key Takeaways
  • SHOP Same-Store Cash NOI grew 13.3% year-over-year
  • SHOP Same-Store Cash Operating Revenue growth of 8% composed of RevPOR growth of 5% and average occupancy growth of 240 basis points
  • Total Company NOI year-over-year growth of 14%
  • Total Company Same-Store Cash NOI year-over-year growth of 6.6%
  • Robust and broad-based resident demand during key selling season with accelerating occupancy growth intra-quarter
  • SHOP Same-Store Cash NOI growth of 15% excluding Q2 2024 property tax refund

“The Company delivered strong earnings growth in the second quarter, led by powerful organic and external growth in our Senior Housing Operating Portfolio.”

Ventas CEO, on the earnings call

Forward Guidance & Outlook

Ventas raised its full year 2025 Normalized FFO per share guidance to $3.41–$3.46 (from $3.36–$3.46 previously), representing 7%–8% year-over-year growth. Attributable Net Income per share guidance was narrowed to $0.47–$0.52 (from $0.43–$0.53). Nareit FFO per share guidance was raised to $3.38–$3.43 (from $3.28–$3.38). The Company increased its 2025 senior housing investment volume expectation to $2.0 billion from $1.5 billion. Key assumptions include ~$1.8 billion of equity raised, G&A expenses of ~$178 million, interest expense of ~$615 million, disposition proceeds of ~$200 million, FAD capital expenditures of ~$285 million, and a weighted average diluted share count of 461 million.

VTR YoY Financials

Q2 2025 vs Q2 2024 · SEC filings Q2 2024 Q2 2025
$0$400.0M$800.0M$1.2B$1.2B$1.4BRevenue$19.4M$68.3MNet Income
$0$400.0M$800.0M$1.2BRevenueNet Income

VTR Revenue by Segment

Senior Housing Operating Portfolio (SHOP)
Outpatient Medical and Research (OM&R)
Triple-Net Leased Properties (NNN)

Figures from SEC filings and company reports. Not investment advice.